ARTICLE
TITLE

Medication Adherence of Tamoxifen to Breast Cancer Patients and the Affecting’s Factors in Dharmais Cancer Hospital Jakarta 10.18196/jmmr.92120

SUMMARY

Several previous studies show that adherence to hormonal therapy increases the survival rate in Breast Cancer (BC) with ER+ or PR+. Tamoxifen is one of oral chemotherapy which is the most used hormonal therapy in breast cancer treatment regimens. The focus of the study was to determine the level of adherence and factors influencing the adherence of the treatment of BC patients undergoing hormonal therapy with Tamoxifen in patients at Dharmais Cancer Hospital in the year 2018. The study is an observational study with a cross-sectional design. The study was followed by 109 respondents. Medication adherence levels assessed via questionnaire modified MARS-5. Sociodemographic and clinical characteristics obtained from interviews using structured questionnaires. Medication adherence’s level of Tamoxifen was 90.9% with the proportion of adhering patients was 75.2% (82 of 109 patients). Multivariate analysis showed that the age of respondents, level of education, level of knowledge is the most influential factor and determine the level of treatment adherence. Education level is the variable that has the greatest effect on medication adherence. Through this study, it is recommended to pay more attention to patients with specific characteristics such as patients with low education and or low income.

PAGES
pp. 100 - 109

 Articles related

Athena Michaelides, Constantina Constantinou    

Breast cancer is the second most common cancer diagnosed worldwide, and the leading cause of cancer death in women. The understanding of disease presentation by patients and health care providers is crucial for a correct diagnosis and management.  P... see more


Hesty Ramadaniati,Ya P. Lee,Jeffery D. Hughes,Lynne Emmerton    

Paediatric patients with cancer are a high-risk patient population for medication misadventures. This study aimed to document and evaluate the role of pharmacists’ interventions during dispensing-related activities in minimising the occurrence of medicat... see more


Ufuoma Miller Fakpor,Ekpe Ekpe Lawson,Omotoso Ayodele Joshua    

Objective: The use of certain medications among diabetic patients put them at risk of developing bladder cancer. This study was done to examine the effects of metformin therapy on the bladder of diabetic patients and to assess the correlation between the... see more


Lou Ann Scarton,Guilherme Del Fiol,Ingrid Oakley-Girvan,Bryan Gibson,Robert Logan,T Elizabeth Workman    

Objective: The research examined complementary and alternative medicine (CAM) information-seeking behaviors and preferences from short- to long-term cancer survival, including goals, motivations, and information sources.Methods: A mixed-methods approach ... see more


Leucemia mielomonocítica aguda y drepanocitosis no tratada con hidroxiurea: A propósito de un caso / Acute Melanocytic Leukemia and Drepanocytosis non-treated with hydroxyurea a case reportLeucemia mielomonocítica aguda y drepanocitosis no tratada con hidroxiurea: A propósito de un caso / Acute Melanocytic Leukemia and Drepanocytosis non-treated with hydroxyurea a case reportLas enfermedades malignas asociadas a la anemia drepanocítica han sido reportadas previamente en un reducido número de pacientes, con el advenimiento de la terapia con hidroxiurea se ha observado un incremento en el riesgo de cáncer en estos enfermos; en nuestro caso clínico no se recoge el antecedente de ingestión de este medicamento. Paciente masculino de 25 años de edad, que acude con crisis hepática, con aumento de ictericia y bilirrubina a expensas de la directa, valores elevados de la transaminasa, hepatomegalia y caída de las cifras de hemoglobina a 40 g/L, blastos de un diámetro de 25 mc, granulares, algunos con núcleos de aspecto monocitoide, componente monocítico en periferia igual a 15%, conteo de leucocitos 120 x109/l,medulograma 80% de células blásticas, componente monocítico mayor del 20%, concluyéndose como Leucemia Mielomonocítica Aguda (LMA M4) según estudios citoquímicos diagnósticos además de un aumento de la lisozima y muramidasa superior a 13 mg lis/ml de plasma (Na acetatoesterasas ) positivo (NASA). Se realiza la plasmaféresis y la exanguinotransfusión haciendo dos recambios con amplia hidratación sin respuesta satisfactoria; el paciente fallece el tercer día del diagnóstico debido a Insuficiencia Respiratoria Aguda. Por lo inusual que resulta y por no existir casos reportados en la literatura Internacional de Síndrome Mieloproliferativo Agudo asociado a la Drepanocitosis no tratados con hidroxiurea, los autores presentan este caso clínico. Palabras clave: Hemoglobinopatía, drepanocitosis, síndrome mieloproliferativo agudo. ABSTRACTMalignant diseases related to sickle-cell anemia have been previously reported in a reduced number of patients, the risk of suffering from cancer in those patients have increased with the advent of the hydroxyurea treatment. In this case no evidence of being taken this medication was proved. A 25-years old male presenting hepatic crisis, jaundice, hyperbilirubinemia, high levels of transaminase, hepatomegaly and low red blood cell counts (40 g/l), blast cells of 25 µm in diameter, granular cell presenting nucleus of monocytic-like cells (some of them), monocytic component in periphery equal to 15 %, leucocytes counts 120x109/l, medullogram: 80 % of blast cells, monocytic component greater than 20 %, concluded as Acute Myelomonocytic Leukemia (AML M4) diagnostic cyto-chemical studies showed an increase of lysozyme and muramidase higher than 13 mg lis/ml of plasma (a positive Na acetatoesterases). A plasmapheresis and ex-transfusion and two rechanges, deep rehydration. No satisfactory response was observed and the patient died on the third day with a diagnose of acute respiratory insufficiency. Because of this unsual disorder and no other cases described by the medical literature as an Acute Myeloproliferative Syndrome in association to Drepanocytosis non-treated with Hydroxyurea motivated the authors to present this case report. Key words: Hemoglobinopathies; drepanocytosis, acute myeloproliferative syndrome.

Anadely Gámez Pérez,Humberto Gámez Oliva,Alfredo Pérez Pedraza,Yaneisy González Portales,Massiel C. Bravo Hernández